Injured by a Defective Product in Ireland? Your Rights Under the 1991 Act (and What's Changing on 9 December 2026)

1. What is the Liability for Defective Products Act 1991?

The Liability for Defective Products Act 1991 is the Irish statute that creates strict liability for producers of defective products. A person injured by a defective product in Ireland can claim compensation from the producer without proving negligence. The Act transposed Council Directive 85/374/EEC [4] and requires only proof of defectiveness and causation.

The 1991 Act covers physical products that cause death, personal injury, or damage to private-use property over €441.41 in value. It runs alongside, not instead of, the older common-law route in negligence. A claimant can pursue both routes in parallel. The advantage of the 1991 Act is the lower bar of proof. The claimant proves the product was defective and that the defect caused the harm. Whether the producer was careless does not matter.

Two amendments have followed since 1991. S.I. 401/2000 [12] brought primary agricultural products and game inside the regime. The next major change is the Revised Product Liability Directive (EU) 2024/2853 ^[3], which Ireland must transpose by 9 December 2026. The next step is to identify who counts as the producer.

2. Who counts as a "producer" under Section 2?

Section 2 of the 1991 Act defines a producer to include five categories. These are the manufacturer of the finished product, the producer of any raw material, the manufacturer of a component part, the own-brander, and the importer into the European Union. Each of these can be sued directly under Irish law.

The five categories matter because liability does not stop at the factory gate. If a multinational makes a product in Asia and an Irish importer brings it into the EU through Dublin, that Irish importer is treated as the producer under Section 2(2). The injured person can sue the Irish entity without having to chase the original maker through foreign courts.

A sixth route runs through Section 2(3). A supplier who cannot identify the producer or the prior supplier within 28 days of a written request becomes liable as if it were the producer itself. This is the supplier-as-producer fallback, where "this" refers to the Section 2(3) shift. It rewards the injured person who keeps the receipt and writes to the retailer promptly. It punishes the supplier who cannot or will not point up the chain.

Joint and several liability under Section 8 [1] also matters. Where two or more producers are liable for the same damage, the injured person can recover the full sum from any of them. The producers then sort out contribution between themselves. This is what happened in Connolly v FÁS and Werkhuizen Landuyt NV [2017] IEHC 472 [10], where a saw machine with a defective sliding table caused finger laceration and amputation injuries to a carpenter on a FÁS upskilling course in Dundalk. The High Court (Cross J.) awarded €281,500, holding the training body two-thirds liable and the manufacturer one-third liable. This leads to the question of how "defective" is defined.

3. What does "defective" mean under Section 5?

Under Section 5 of the 1991 Act, a product is defective when it fails to provide the safety which a person is entitled to expect, considering all circumstances. Those circumstances include the product's presentation, foreseeable use, and the time it was put into circulation.

The test is objective. It is not what this particular consumer expected, but what the public is entitled to expect. A garden lawnmower is allowed to cut grass. It is not allowed to discharge a stone at the operator's eye through a guard that fails under foreseeable use. The same product might be defective in 2026 even though a 1995 version of the same machine was acceptable. The Act explicitly recognises that safety standards rise over time, and Section 5(2) blocks the producer from arguing that a later, safer product proves the earlier one was defective.

Three flavours of defect commonly appear in Irish cases. Design defects exist where the product line is unsafe by intention. Manufacturing defects occur where one batch or one item deviates from the design. Failure-to-warn defects arise where instructions or labelling do not put the consumer on notice of a real risk.

The Court of Appeal addressed the limits of the failure-to-warn argument in Cekanova v Dunnes Stores [2021] IECA 12 [11]. A glass jug shattered when filled with very hot water. The High Court had awarded the plaintiff over €56,000 in negligence. The Court of Appeal (Noonan J.) overturned that finding, holding that it is universally known to reasonable adults of normal intelligence that very hot water has the potential to shatter an ordinary glass vessel, and that no warning was required. The plea under the 1991 Act was not actively pursued. The case marks the limit of failure-to-warn arguments for everyday products whose risks fall within ordinary consumer knowledge.

4. How long do I have to claim? The two clocks under Section 7

Section 7 of the 1991 Act creates two limitation clocks for Irish product injury claims. The 3-year clock runs from when you know of the damage, the defect, and the producer's identity. The 10-year long-stop runs from circulation, regardless of when the damage emerged. We call this the two clocks of Section 7: the 3-year discovery clock from date of knowledge, and the 10-year long-stop from circulation, running in parallel until whichever expires first ends the claim.

Unlike in England and Wales, where the equivalent regime sits in the Consumer Protection Act 1987, in Ireland the 1991 Act creates a 3-year discovery window with a 10-year long-stop. The two clocks run independently. Whichever expires first ends the claim.

The 3-year clock under Section 7(1) requires three pieces of knowledge before it starts: knowledge of the damage, knowledge that the damage was caused by the defect, and knowledge of the producer's identity. Until all three are present, the clock has not begun. This matters for late-emerging injuries, where symptoms surface years after exposure.

The 10-year clock under Section 7(2)(a) is harsher. It runs from when the producer placed the individual product on the market, not from when the model was first launched. From handling product liability matters across both consumer goods and implanted devices, the silent killer in long-tail cases is the 10-year long-stop, not the better-known 3-year discovery clock.

Worked example. A patient receives a hip implant in 2016. Pain and revision surgery follow in 2025. Knowledge of the damage, defect, and producer arrives in mid-2025. The 3-year discovery clock would run to mid-2028. But the 10-year long-stop expires in 2026, ten years after the implant entered circulation. The claim must be filed by 2026 to survive. This rule sits behind every major medical-device action in Ireland and explains why date of knowledge work cannot be left until late.

5. What can I claim for? Heads of damage under the Act

Under Section 1 of the 1991 Act, recoverable damage includes death, personal injury, and damage to private-use property exceeding €441.41 in value. Pain and suffering follow the Personal Injuries Guidelines (2021) [9], and economic losses must be vouched in the same way as any Irish personal injury claim.

Three categories make up most product claim awards. General damages cover pain, suffering, and loss of amenity, and follow the Personal Injuries Guidelines (2021) bands that replaced the older Book of Quantum. Special damages cover financial losses such as medical expenses, loss of earnings, and travel for treatment. Property damage applies only to private-use items above the €441.41 threshold under Section 3, and the Act does not cover damage to the defective product itself.

The €441.41 threshold under Section 3 is a feature, not a drafting accident. Below it, the 1991 Act does not apply to the property loss, but the claimant retains the ordinary common-law route in negligence or contract. Above it, the strict-liability route under the 1991 Act becomes available alongside those routes. The choice of cause of action turns on what evidence the claimant can muster, because negligence requires proof of carelessness while the 1991 Act does not.

6. What defences can the producer raise? The six statutory defences under Section 6

Section 6 of the 1991 Act sets out six statutory defences a producer can raise. These cover non-circulation, defects arising after circulation, non-commercial supply, mandatory regulatory compliance, the development risks defence, and component-supplier defences. A successful defence defeats the claim.

Non-circulation under Section 6(a) applies where the producer never placed the product on the market. A stolen prototype that injures the thief is the textbook example. Defects arising after circulation under Section 6(b) cover situations where the product was safe when supplied and became defective through misuse, poor storage, or third-party tampering. Non-commercial supply under Section 6(c) covers products distributed outside any business activity, such as an inventor giving a sample to a friend.

Mandatory regulatory compliance under Section 6(d) is narrow. It only applies where the defect resulted from compliance with a binding rule of law, not where the producer chose to follow a voluntary standard. The component-supplier defence under Section 6(f) lets the maker of a component escape liability where the defect was caused by the design of the finished product or the instructions of the assembler.

The most contested defence is the development risks defence under Section 6(e). It excuses the producer where the state of scientific and technical knowledge at the time of circulation was not such that the existence of the defect could be discovered. This is the producer's strongest weapon in pharmaceutical and emerging-technology cases.

Contributory negligence under Section 9 reduces but does not bar recovery. It mirrors the proportionate-reduction approach in the Civil Liability Act 1961. Section 10 then prevents the producer from contracting out of these rules. Any clause purporting to exclude or limit liability under the 1991 Act is void.

7. How do defective medical device and pharmaceutical claims work in Ireland?

Defective medical device claims in Ireland sit within the 1991 Act's strict liability framework alongside EU medical device regulation. The Health Products Regulatory Authority (HPRA) [8] recalls approximately 150 or more medical devices in Ireland each year, generating the largest cluster of high-value product claims, including DePuy hip implants and transvaginal mesh.

The DePuy ASR hip cluster gives the clearest Irish picture. Around 3,300 to 3,500 Irish patients received the ASR XL implant before its 2010 worldwide recall. Sixteen public hospitals and fourteen private hospitals fitted the device. Cobalt and chromium ion release caused inflammation, soft tissue necrosis, and the need for revision surgery. The High Court addressed this directly in Dineen v DePuy International Ltd [2017] IEHC 723. A known but tolerated risk does not stop being a defect just because the manufacturer disclosed it.

A detail that catches many medical device patients off guard: the long-stop clock under Section 7(2)(a) keeps running through years of revision surgery, hospital follow-ups, and recall correspondence. The clock measures from circulation, not from your last hospital appointment.

Pharmaceutical claims raise similar issues. The Pandemrix narcolepsy litigation produced approximately 100 High Court cases in Ireland, with the lead test case Bennett v Minister for Health, HSE, GSK and HPRA settling without admission of liability in November 2019, and the Department of Health and HSE bearing the costs and compensation. The Court of Justice of the EU framed the standard for high-risk pharmaceuticals in Boston Scientific Medizintechnik (Joined Cases C-503/13 and C-504/13)^[13]. The court held that where one device in a series is shown defective, the entire batch can be presumed defective without testing each individual unit. For Irish DePuy ASR claimants and similar cohorts, this matters at a practical level. If statistical or recall evidence proves a model is unsafe, the claimant does not need to prove that their specific implant failed for an internal reason. The defect is taken as established at the batch or model level.

8. Should I claim under the 1991 Act or in medical negligence? Picking the right route

A defective product claim and a medical negligence claim are different actions in Irish law. The product claim targets the manufacturer of a defective device or drug under the 1991 Act, requiring no proof of negligence. The medical negligence claim targets the clinician or hospital under the Dunne principles, and requires proof of negligence.

The two can run in parallel for the same patient. A defective product claim is not a medical negligence claim. The product claim targets the manufacturer. The medical negligence claim targets the clinician or hospital. The legal tests, the time limits, and the procedural routes are different.

Whether to bring a claim under the 1991 Act, in negligence, or both depends on the strength of the evidence and the limitation periods that apply. Many Irish device cases run the product claim against the manufacturer in the High Court while the patient retains the option of a separate medical negligence action against the implanting hospital.

9. How to make a claim under the Act, step by step

To claim under the 1991 Act in Ireland, you submit an application to the Injuries Resolution Board, formerly known as the Personal Injuries Assessment Board (PIAB) until 2023, with a medical report and a claim form. You then either accept the assessment or proceed to court. Most product claims, unlike medical negligence claims, must go through the IRB before any court proceedings can begin.

Unlike in England and Wales, where there is no equivalent body, in Ireland most defective product personal injury claims must first go through the Injuries Resolution Board before any court proceedings.

1. Preserve the product and the proof. Keep the product, the packaging, the receipt, the user manual, and any safety alerts or recall correspondence. Photograph the defect and any visible injury.
2. Get medical attention and a written report. Your GP or hospital chart is the foundation of any claim. The IRB requires a medical report on Form B from your treating doctor.
3. Identify the producer. The product label, packaging, or HPRA field safety notice will usually name the producer. Keep written copies of everything.
4. Apply to the IRB. File Form A with the IRB and pay the application fee. The Board acknowledges within a few weeks and writes to the producer.
5. Section 8 notice. Where High Court proceedings will follow, your solicitor issues a Section 8 letter within one or two months of the cause of action.
6. Accept, reject, or proceed. If both sides accept the IRB's assessment, the order is paid out. If either side rejects, the IRB issues an authorisation to bring the matter to court.

What the standard guidance does not account for: when the producer is based in another EU state, you can still serve the claim through the Irish IRB process. The practical difficulties of expert evidence and translation can stretch the timeline by 6 to 12 months.

Section 4 of the 1991 Act places the burden of proof on the claimant across three elements. The claimant must prove that the product was defective, that the claimant suffered damage of the kind covered by the Act, and that the defect caused the damage. The Court of Justice clarified the third element in N.W. and Others v Sanofi Pasteur MSD SNC (Case C-621/15)^[14]. The court held that strict liability does not require scientific certainty on causation. National courts can find causation on serious, specific, and consistent indicia, even where the general medical literature is inconclusive. For Irish claimants whose injury sits at the edge of mainstream medical evidence, including vaccine reactions, slow-onset implant failures, or rare drug interactions, this is the doctrinal bridge between weak evidence and a winnable case.

Meeting that burden costs money. The claimant pays for expert reports up front, including engineering analysis for consumer goods, materials testing for implants, or pharmacology for drugs. A modest engineering report might cost €1,500 to €3,000. A full medical-device explant analysis can run into five figures. These costs are recoverable as part of the special damages if the case succeeds, but the funding decision sits with the claimant or the solicitor at the start, not at the end.

10. What's changing on 9 December 2026? The Revised Product Liability Directive

Directive (EU) 2024/2853, the Revised Product Liability Directive, must be transposed into Irish law by 9 December 2026. From that date, products placed on the Irish market will be governed by an updated regime that includes software, AI, expanded heads of damage, and a long-stop of up to 25 years.

The new directive is the largest change to product liability in Ireland since 1991. It does not erase the 1991 Act for older products. It governs products placed on the market on or after the transposition date. The 1991 Act continues to govern earlier products. The decision to wait for the Revised PLD or to file under the 1991 Act depends entirely on the date the individual product was placed on the market. This is the practical force of the 9 December 2026 cliff.

The triangulation here matters. Source A is the 1991 Act. Source B is Directive 2024/2853. Source C is the Department of Enterprise, Trade and Employment [5] transposition timetable, which confirms the 9 December 2026 date will be met. Putting the three together produces the practical insight: the same product injury, fourteen days apart on either side of 9 December 2026, will be litigated under fundamentally different rules. The placement-on-market date of the individual product, not the injury date, decides which regime applies.

Adjacent regime, not a substitute. The General Product Safety Regulation, transposed by S.I. 726/2024, governs product safety obligations and recall powers across the EU from 13 December 2024. It supplements but does not replace the 1991 Act for personal injury claims. A defective product can breach both regimes at once.

What most guides miss about defective product claims in Ireland

Three points get under-reported in published Irish guidance, and each can change a case outcome.

The long-stop kills more cases than the discovery clock. Most online guides emphasise the 3-year limit. The 10-year long-stop under Section 7(2)(a) ends silently and cannot be extended for date-of-knowledge reasons. A patient who only connects an injury to a 9-year-old implant has months, not years, to file.

The 1991 Act runs in parallel with negligence, not in place of it. Section 11 expressly preserves common-law rights. A claimant can plead strict liability against the producer and negligence against the supplier or installer in the same proceedings. Most guides treat these as alternatives. They are cumulative.

The Revised PLD is not a tweak. Software, AI behaviour, cybersecurity defects, and medically evidenced psychological harm all sit inside the regime from 9 December 2026. Most guides written before late 2024 either ignore this or describe the old 1991 framework as if it were permanent.

What if your situation does not fit any of these patterns?

Many product injury cases sit outside the standard fact pattern. Imported goods with no Irish supplier of record. Second-hand sales. Products discontinued before purchase. Software updates that change a device's behaviour years after sale. The frequently asked questions below address the cases that come up most often, and the related questions section after that addresses likely follow-ups.

Frequently Asked Questions

Related Questions

Can I claim if I gave the product to someone else and they were injured?

The injured person owns the claim, not the buyer. The 1991 Act protects users and bystanders. A parent who buys a defective toy that injures a child can bring the claim on the child's behalf.

What if the product was discontinued before I bought it?

Discontinuation does not remove producer liability. The 10-year long-stop runs from when the individual product was placed on the market, not from when the model was retired.

Can I bring both a 1991 Act claim and a negligence claim at the same time?

Yes. The 1991 Act is supplementary, not exclusive. Section 11 expressly preserves common-law remedies. Many serious cases run a strict-liability claim against the producer alongside a negligence claim against the supplier or installer.

Key takeaways

• Strict liability without negligence. The Liability for Defective Products Act 1991 lets an injured person in Ireland recover from the producer on proof of defectiveness and causation only.
• Two clocks under Section 7. Three years from date of knowledge under Section 7(1), and a ten-year long-stop from circulation under Section 7(2)(a). Whichever expires first ends the claim.
• Producer cascade under Section 2. Manufacturers, raw material producers, component producers, own-branders, and EU importers are all producers. A supplier becomes liable as a producer if the producer cannot be identified within 28 days of a written request under Section 2(3).
• Property threshold of €441.41. Below this figure, the 1991 Act does not apply to property loss, but the common-law route in negligence or contract remains available.
• Six defences under Section 6. Including development risks, regulatory compliance, and the component-producer defence. None requires proof of reasonable care.
• Most claims start at the IRB. The Injuries Resolution Board, formerly PIAB, processes the claim before any High Court proceedings.
• Personal Injuries Guidelines 2021 govern damages. The Guidelines replaced the older Book of Quantum and apply to defective product claims as to any other personal injury claim.
• The 9 December 2026 cliff. Products placed on the Irish market before that date remain under the 1991 Act. Products placed on the market on or after that date will be governed by the transposed Revised Product Liability Directive.

Glossary of key terms

Defective product

Under Section 5 of the Liability for Defective Products Act 1991, a product is defective if it fails to provide the safety which a person is entitled to expect, taking all circumstances into account, including the presentation of the product, its reasonably expected use, and the time at which it was placed in circulation.

Producer

Under Section 2, includes the manufacturer of a finished product, the producer of a raw material, the manufacturer of a component, an own-brander, and any person who imports a product into the EU. A supplier who fails to identify the producer within 28 days of a written request is treated as the producer under Section 2(3).

Strict liability

Liability that does not require proof of fault or negligence. Under the 1991 Act, the producer is liable in damages for personal injury caused by a defect in the product, irrespective of how careful the producer was in design or manufacture.

Date of knowledge

The date on which the claimant first knew, or could reasonably have known, of the damage, the defect, and the identity of the producer. The 3-year discovery clock under Section 7(1) runs from this date.

Long-stop

An absolute time limit running from the date the producer placed the actual product in circulation, regardless of when the damage emerged or was discovered. The 1991 Act long-stop under Section 7(2)(a) is 10 years. The Revised Product Liability Directive will extend this to up to 25 years for late-emerging injuries.

Date of circulation

The date on which the producer first placed the actual physical product in question into the supply chain. This is the date that starts the long-stop, not the date the model was launched or the date of retail sale.

Joint and several liability

Where two or more producers are liable for the same damage under Section 8, the injured person can recover the full sum from any one of them. The producers then sort out contribution between themselves under Part III of the Civil Liability Act 1961.

Development risks defence

One of the six defences under Section 6. The producer is not liable if, at the time the product was placed in circulation, the state of scientific and technical knowledge was not such as to allow the existence of the defect to be discovered.

Injuries Resolution Board (IRB)

The independent statutory body that assesses personal injury claims in Ireland. Most defective product claims start at the IRB, formerly known as the Personal Injuries Assessment Board, before any High Court proceedings can be issued.

The two clocks of Section 7

The 3-year discovery clock under Section 7(1) of the 1991 Act, running from the claimant's date of knowledge of damage, defect, and producer identity, and the 10-year long-stop under Section 7(2)(a), running from when the producer placed the product in circulation. Both clocks run in parallel and whichever expires first ends the claim.

The 9 December 2026 cliff

The date on which Ireland's transposition of Directive (EU) 2024/2853 (the Revised Product Liability Directive) takes effect. Products placed on the Irish market before that date remain governed by the 1991 Act. Products placed on the market on or after that date will be governed by the transposed Revised Product Liability Directive.